Scientific Reports · 2021 · 12 citations · 55 references
EngineeringBiomedical EngineeringOncologyBiomedical ImagingBiomedical OpticsDiagnostic ImagingCancer NanomedicineNanomedicineOptical ImagingTargeted Imaging AgentsTheranostic NanoparticlesTumor ImagingContrast Agent SynthesisIn Vivo ImagingNanoparticle Contrast AgentsNanoparticle Imaging AgentsNanoparticle Imaging ProbesNanoparticlesOptical Contrast AgentsSilica-based Nanoparticles
Optoacoustic imaging is a new biomedical imaging technology with clear benefits over traditional optical imaging and ultrasound. While the imaging technology has improved since its initial development, the creation of dedicated contrast agents for optoacoustic imaging has been stagnant. Current exploration of contrast agents has been limited to standard commercial dyes that have already been established in optical imaging applications. While some of these compounds have demonstrated utility in optoacoustic imaging, they are far from optimal and there is a need for contrast agents with tailored optoacoustic properties. The synthesis, encapsulation within tumor targeting silica nanoparticles and applications in in vivo tumor imaging of optoacoustic contrast agents are reported.
55
Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations
Medicine, Oncology, Pharmacotherapy +16
Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds
Alison P. Klein, Kieran Brune, Gloria M. Petersen et al. · Cancer Research · 2004 · 681 citations